Extending limits of resection for metastatic colorectal cancer

Risk benefit ratio

Anthony D. Yang, Antoine Brouquet, Jean Nicolas Vauthey

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Improvements in treatment strategies and a better knowledge of tumor biology have contributed to an increase in the number of patients with colorectal liver metastases (CLM) who are candidate for surgery. These progresses are on going and the introduction of effective systemic therapy agents contributes further to the increase in the resectability of patients with advanced CLM. © 2010 Wiley-Liss, Inc.

Original languageEnglish (US)
Pages (from-to)996-1001
Number of pages6
JournalJournal of Surgical Oncology
Volume102
Issue number8
DOIs
StatePublished - Dec 15 2010
Externally publishedYes

Fingerprint

Colorectal Neoplasms
Odds Ratio
Neoplasm Metastasis
Liver
Therapeutics
Neoplasms

Keywords

  • chemotherapy
  • colorectal cancer
  • liver metastases
  • resectability

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Extending limits of resection for metastatic colorectal cancer : Risk benefit ratio. / Yang, Anthony D.; Brouquet, Antoine; Vauthey, Jean Nicolas.

In: Journal of Surgical Oncology, Vol. 102, No. 8, 15.12.2010, p. 996-1001.

Research output: Contribution to journalArticle

Yang, Anthony D. ; Brouquet, Antoine ; Vauthey, Jean Nicolas. / Extending limits of resection for metastatic colorectal cancer : Risk benefit ratio. In: Journal of Surgical Oncology. 2010 ; Vol. 102, No. 8. pp. 996-1001.
@article{406992b53b0f4403a243fab6751993ed,
title = "Extending limits of resection for metastatic colorectal cancer: Risk benefit ratio",
abstract = "Improvements in treatment strategies and a better knowledge of tumor biology have contributed to an increase in the number of patients with colorectal liver metastases (CLM) who are candidate for surgery. These progresses are on going and the introduction of effective systemic therapy agents contributes further to the increase in the resectability of patients with advanced CLM. {\circledC} 2010 Wiley-Liss, Inc.",
keywords = "chemotherapy, colorectal cancer, liver metastases, resectability",
author = "Yang, {Anthony D.} and Antoine Brouquet and Vauthey, {Jean Nicolas}",
year = "2010",
month = "12",
day = "15",
doi = "10.1002/jso.21701",
language = "English (US)",
volume = "102",
pages = "996--1001",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",
number = "8",

}

TY - JOUR

T1 - Extending limits of resection for metastatic colorectal cancer

T2 - Risk benefit ratio

AU - Yang, Anthony D.

AU - Brouquet, Antoine

AU - Vauthey, Jean Nicolas

PY - 2010/12/15

Y1 - 2010/12/15

N2 - Improvements in treatment strategies and a better knowledge of tumor biology have contributed to an increase in the number of patients with colorectal liver metastases (CLM) who are candidate for surgery. These progresses are on going and the introduction of effective systemic therapy agents contributes further to the increase in the resectability of patients with advanced CLM. © 2010 Wiley-Liss, Inc.

AB - Improvements in treatment strategies and a better knowledge of tumor biology have contributed to an increase in the number of patients with colorectal liver metastases (CLM) who are candidate for surgery. These progresses are on going and the introduction of effective systemic therapy agents contributes further to the increase in the resectability of patients with advanced CLM. © 2010 Wiley-Liss, Inc.

KW - chemotherapy

KW - colorectal cancer

KW - liver metastases

KW - resectability

UR - http://www.scopus.com/inward/record.url?scp=78650654539&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650654539&partnerID=8YFLogxK

U2 - 10.1002/jso.21701

DO - 10.1002/jso.21701

M3 - Article

VL - 102

SP - 996

EP - 1001

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 8

ER -